Computerised cognitive testing of individuals with Down's syndrome and Alzheimer's disease.

Gutman et al. (2016) tracked the same adults with Down syndrome and Alzheimer’s disease for 18 months.

They gave the NeuroTrax computerized battery every few months to see if scores stayed steady.

The goal was to check if the test could reliably spot change when it really happens.

Memory, executive, verbal, and visuospatial scores did not drift over the year and a half.

The test-retest numbers stayed tight, meaning the battery is stable for long-term use.

Prasher et al. (2004) already showed the 15-item ABDQ caregiver quiz screens dementia with 92 % accuracy. Michael’s team moves the field forward by proving a computerized battery can also stay steady over time.

Moya et al. (2022) used a French recall test to separate adults with Down syndrome plus Alzheimer’s from those without. Both studies use small case series, but different tools—mCRT versus NeuroTrax—giving clinicians more than one option.

Waldron et al. (2023) warn that most inhibitory-control tasks flop in youth with Down syndrome. Michael’s work counters that concern for adults by showing global cognitive scores that do hold up.

You now have evidence that NeuroTrax won’t give you fake decline or fake gain across 18 months. Use it to track adults with Down syndrome and suspected dementia without second-guessing the numbers.